Page last updated: 2024-09-03

safinamide and Alzheimer Disease

safinamide has been researched along with Alzheimer Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Alcaro, S; Bagetta, D; Borges, F; Cagide, F; Oliveira, PJ; Ortuso, F; Pérez, C; Reis, J; Rodríguez-Franco, MI; Teixeira, J; Uriarte, E; Valencia, ME1
Bo, R; Liu, K; Wang, X; Xu, B; Xu, T; Yuan, Y; Zhou, J; Zhou, S1
Alcaro, S; Bagetta, D; Burke, AJ; Carreiro, EP; Fernández-Bolaños, JG; Hagenow, S; Leitzbach, L; López, Ó; Marques, C; Moutayakine, A; Stark, H1
Ågren, H; Chiotis, K; Lemoine, L; Murugan, NA; Nordberg, A; Rodriguez-Vieitez, E1

Other Studies

4 other study(ies) available for safinamide and Alzheimer Disease

ArticleYear
Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors.
    European journal of medicinal chemistry, 2018, Oct-05, Volume: 158

    Topics: Alzheimer Disease; Blood-Brain Barrier; Cholinesterase Inhibitors; Cholinesterases; Chromones; Drug Design; Hep G2 Cells; Humans; Ligands; Molecular Docking Simulation; Molecular Targeted Therapy; Monoamine Oxidase; Monoamine Oxidase Inhibitors

2018
Discovery of 3, 6-disubstituted isobenzofuran-1(3H)-ones as novel inhibitors of monoamine oxidases.
    Bioorganic & medicinal chemistry letters, 2022, 07-01, Volume: 67

    Topics: Alzheimer Disease; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship

2022
Evaluation of chromane derivatives: Promising privileged scaffolds for lead discovery within Alzheimer's disease.
    Bioorganic & medicinal chemistry, 2022, 08-15, Volume: 68

    Topics: Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Horses; Kinetics; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship

2022
Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging.
    European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:6

    Topics: Aged; Alanine; Alzheimer Disease; Benzylamines; Binding Sites; Brain; Computational Biology; Computer Simulation; Female; Humans; Ligands; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Docking Simulation; Monoamine Oxidase; Positron-Emission Tomography; Protein Binding; Protein Conformation; Radiopharmaceuticals; Retrospective Studies; tau Proteins

2019